Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial

Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, Nienke Kuijsters, S Kommoss, Friederike L A Koppe, Marlies E Nowee, Henrike Westerveld, Maria A A De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Ina M. Jürgenliemk‐Schulz, Katrien Vandecasteele, Moritz Hamann, M. Kiderlen, Annette Staebler, Hans W. Nijman, Bastiaan G. Wortman, Elefteria Asteinidou, Stephanie M. de Boer, Wilbert van den Hout, Karen Verhoeven-Adema, Remi A. Nout, Hein Putter, Tjalling Bosse, Carien L. Creutzberg